Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Patrick John Finn, COO of Twist Bioscience, sold 476 shares of common stock on July 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On July 2, 2024, Patrick John Finn, the President and COO of Twist Bioscience Corp, sold 476 shares of common stock.
- The sale was executed at a price of $48.002 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Finn directly owns 173,419 shares of Twist Bioscience Corp.
- The sale was mandated by Twist Bioscience's equity incentive plans, requiring tax withholding obligations to be funded through a 'sell to cover' transaction.
Sentiment
Score: 5
Explanation: The document describes a routine transaction related to tax obligations, which is neutral in sentiment.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest.
Stakeholder Impact
- The sale has a minimal impact on shareholders as it is a small transaction related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 07/02/2024 | Date of stock sale transaction |
| 07/05/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.